Aspen Grove Capital, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Aspen Grove Capital, LLC

  • $452 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.28 - $1.16 $2,800 - $11,600
10,000 Added 6.67%
160,010 $53.5 Million
Q1 2024

May 15, 2024
BUY
$1.06 - $1.67 $31,800 - $50,100
30,000 Added 25.0%
150,010 $174 Million
Q4 2023

Feb 14, 2024
BUY
$1.26 - $1.79 $126,012 - $179,017
100,010 Added 500.05%
120,010 $161 Million
Q1 2023

May 15, 2023
BUY
$1.2 - $2.19 $24,000 - $43,800
20,000 New
20,000 $26.6 Million

Others Institutions Holding DNA

# of Institutions
43
Shares Held
48.4M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Aspen Grove Capital, LLC Portfolio

Follow Aspen Grove Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspen Grove Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspen Grove Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email